ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

KPV

KPV

Also known as: KPV Tripeptide, Alpha-MSH Fragment 11-13

Overview

Key Facts

Primary Goal: Research and therapeutic applications of KPV

Inhibits NF-kB nuclear translocation and transcriptional activity. Reduces pro-inflammatory cytokine secretion (TNF-alpha, IL-6, IL-1-beta).

Dosing Information

Half-Life

~30 minutes

Typical Dose

200–500 mcg

Frequency

1-2x daily

Cycle Length

4-12 weeks

Administration Routes:
subcutaneousoraltopical

Benefits

  • Potent anti-inflammatory without broad immunosuppression
  • Reduces intestinal mucosal inflammation
  • Direct antimicrobial activity against bacteria and Candida
  • Modulates innate immune response in gut epithelium
  • Crosses the blood-brain barrier for neuroinflammation reduction
  • Supports immune homeostasis in chronic inflammatory conditions

Side Effects

Injection site redness (mild)mild
Slight fatigue (rare)mild
GI discomfort with oral use (uncommon)mild

Mechanism of Action

1

Inhibits NF-kB nuclear translocation and transcriptional activity

2

Reduces pro-inflammatory cytokine secretion (TNF-alpha, IL-6, IL-1-beta)

3

Enters colonic epithelial cells to directly suppress inflammasome activation

4

Modulates MAPK signaling pathways in immune cells

5

Exhibits direct membrane-disrupting antimicrobial activity

Contraindications

Do not use this peptide if any of the following apply:

  • Pregnancy or breastfeeding
  • Active immunosuppressive therapy
  • Autoimmune conditions (consult physician)

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2 weeks

Research Summary

Preclinical

Studied in preclinical models of inflammatory bowel disease, colitis, and skin inflammation. Demonstrated efficacy comparable to standard anti-inflammatory treatments in murine IBD models. Strong in vitro evidence for NF-kB inhibition. Cross-reference: see kpv in healing-recovery for tissue repair context.

Frequently Asked Questions

Common questions about KPV

UK-Specific Information

Exclusive data points and guidance for UK residents using KPV

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok